Anika Therapeutics announces Canadian distribution agreement for Elevess

October 3, 2008

Bedford, Mass. - Anika Therapeutics has signed an agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.

Bedford, Mass.

- Anika Therapeutics has signed an exclusive agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.

Elevess is the first hyaluronic acid filler with lidocaine to be approved by the U.S. Food and Drug Administration.